We are delighted to be working with Optos, Moorfields Eye Hospital and Queens University Belfast on a research project that has just won the Artificial Intelligence (AI) in Health and Care Award run by the Accelerated Access Collaborative in partnership with NHSX and the National Institute for Health Research. The Award supports technologies across the spectrum of development from initial feasibility to evaluation within the NHS.
The funding will be used to accelerate the implementation and validation of AI to support the early detection of Diabetes related eye-disease into NHS Diabetic Eye Screening practices. The award will fund a clinical study exploring if automated grading is clinically and cost effective for the NHS’ Diabetic Eye Screening Programme (DESP).
InHealth Intelligence is the leading provider of diabetic eye screening services in the UK, with a cohort of over 1,000,000 patients from eleven programmes across England. We will use our expertise and software, Spectra, to support the integration of the AI into screening services at a larger scale.
We are delighted to be working with Optos, Moorfields Eye Hospital and researchers from Queens University Belfast to share resources and support the study.
Phil Kirby, Managing Director of InHealth Intelligence said “I am delighted to be working with Optos Plc, Moorfields Eye Hospital and Queens University Belfast on this important initiative.”
Rob Kennedy, Optos CEO, said: “Being selected for this award is a huge achievement for all the team. We look forward to working closely with Moorfields Eye Hospital, Queens University Belfast and InHealth Intelligence to undertake this very important study.”